VENICE, Fla., March 15, 2011 /PRNewswire/ -- SinoFresh®
HealthCare, Inc., (Pink Sheets: SFSH) announced today that its CEO,
David Olund, will remain in
Europe this week to continue talks
with a number of international distributors.
Mr. Olund embarked on a one week mission to Europe to meet with distributors interested in
selling SinoFresh's patented Antiseptic Nasal and Sinus Care Spray
across Europe and throughout
Asia. The meetings, arranged with
leading healthcare distribution companies, were initiated by the
European and Asian firms for the purpose of introducing SinoFresh
to these markets. This expansion of the sales base will serve to
more than double the Company's prospective market and make
SinoFresh available to more than 2 billion people globally.
The European talks are part of the Company's broader growth
program which includes the recently signed distribution agreement
with Cardinal Health and the inclusion of SinoFresh Antiseptic
Nasal and Sinus Care Spray on major e-commerce websites. SinoFresh
is also now available directly from the Company's website at
www.sinofresh.com.
David R. Olund, CEO states, "The
talks here are going extremely well. Not only have I had the
opportunity to discuss significant sales growth with major
distributors, but I also have additional meetings planned that were
unexpected when I departed from Florida last week. This tremendous interest in
our product has encouraged me to stay a bit longer to advance these
talks even further. I am now more confident than ever that
SinoFresh will soon be available to a broad, global market."
SinoFresh HealthCare, Inc. is a publicly traded
company (Pink Sheets: SFSH) based in Venice, Florida, that manufactures and
distributes nasal, oral and topical antiseptic germ-killing
products. SinoFresh products are marketed and distributed globally
through a network of strategic wholesale and retail partners.
SinoFresh Healthcare, Inc's, premier product, SinoFresh Antiseptic
Homeopathic Nasal spray has in laboratory tests shown effective
antiseptic capability against a variety of pathogens such as MRSA,
E-Coli, H1N1 and a broad range of other viruses, molds, fungi and
bacteria.
This press release includes forward-looking statements intended
to qualify for the safe harbor from liability established by the
Private Securities Litigation Reform Act of 1995. Our
forward-looking statements express our current expectations or
forecasts of possible future results or events, including
projections of future performance, statements of management's plans
and objectives, future contracts, and forecasts of trends and other
matters. Forward-looking statements speak only as of the date of
this filing, and we undertake no obligation to update or revise
such statements to reflect new circumstances or unanticipated
events as they occur. You can identify these statements by the fact
that they do not relate strictly to historic or current facts and
often use words such as "anticipate", "estimate", "expect",
"believe", "will likely result", "outlook", "project" and other
words and expressions of similar meaning. No assurance can be given
that the results in any forward-looking statements will be achieved
and actual results could be affected by one or more factors, which
could cause them to differ materially. For these statements, we
claim the protection of the safe harbor for forward-looking
statements contained in the Private Securities Litigation Reform
Act.
Contact:
|
|
SinoFresh HealthCare,
Inc.
|
|
Investor Relations
|
|
941.375.8174 option 8
|
|
|
SOURCE SinoFresh HealthCare, Inc.